作　　者： (孙丽娟）; (李淑瑾）; (付光平）; (白梅）; (董春楠）; (杨波）; (陈平忍）; (王占东）; (付丽红）; (丛斌）;

机构地区： 河北医科大学法医学院,河北石家庄050017

出　　处： 《中国法医学杂志》 2017年第4期350-353,358,共5页

摘　　要： 目的探讨妇科肿瘤组织和乳腺癌组织的法医学常用STR基因座突变类型和规律,以及显微切割技术在肿瘤组织法医学鉴定中的应用。方法应用Power Plex 21 System和Argus X-12试剂盒对62例乳腺癌患者,62例妇科恶性肿瘤患者,10例良性妇科肿瘤患者外周血、肿瘤组织和癌旁组织DNA样本进行复合扩增,获得STR分型,并选取存在突变的部分肿瘤组织进行显微切割。结果妇科恶性肿瘤患者外周血的STR分型与癌旁组织一致;46.77%的妇科恶性肿瘤组织中观察到4种STR突变类型,显著高于良性肿瘤的STR突变率(P<0.01)和乳腺癌的STR突变率(P=0.009)。显微切割获得的间质细胞的STR分型与癌旁组织一致。结论本研究所检测的STR基因座在妇科恶性肿瘤组织中的稳定性较差,不适用于该系统肿瘤组织的法医学鉴定;显微切割技术可准确分离间质细胞,能够代表肿瘤来源个体的正常DNA分型,是解决此类案件法医学鉴定的一种有效方法。 Objective To explore the mutation types and disciplines of STR commonly used in forensic in gynecologic and breast cancerand investigate the application of microdissection in forensic practice involving tumor tissue. Methods DNA of tumor tissues, adjacent normal tissues and peripheral blood from 62 patients with breast cancer, 62 patients with gynecologic cancer and 10 patients with benign gynecologic tumor were amplified by Power Plex 21 System kit and Argus X-12 kit. Capillary electrophoresis of PCR products was carried out on an ABI 3130 Genetic Analyzer to obtain genotypes. Some tumor tissues with STR variation were microdissected. Results The genotype of peripheral blood in cancer patient was consistent with that of corresponding normal tissue. 4 types of STR variations were found in 46.77% gynecologic cancer tissues, compared with that in benign tumor tissues and breast cancer, the difference of STR variation was significant（P〈0.01,P=0.009）. The genotype of stromal cells separated by microdissection was consistent with that of corresponding adjacent normal tissue. Conclusion The STR loci detected in the study with poor stability are not suitable for forensic cases involving gynecologic cancer tissues. The genotype of stromal cells separated accurately from tumor tissues by microdissection could represent the normal DNA genotype of the individual with cancer. Microdissection is an effective solution in forensic cases with tumor tissues.

关 键 词： 法医物证学 妇科肿瘤组织 乳腺癌组织 突变 显微切割